ArticleNature and science of sleep2025
Associations of Sleep-Disordered Breathing and Insomnia with Incident Metabolic Syndrome - The Hispanic Community Health Study/Study of Latinos.
Article in Nature and science of sleep, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Banxia Shumi Decoction Alleviates PCPA-Induced Insomnia and Regulates ADAM10 Expression via Melatonin Signaling in Rats.CNS neuroscience & therapeutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Metabolic syndrome (MS) is a common disease associated with multiple cardiovascular risk factors. Sleep-disordered breathing (SDB) and insomnia are associated with several metabolic components, such as hypertension, diabetes, dyslipidemia, and obesity. Although studies have shown an association between these sleep disorders and MS, the longitudinal relationship in the US Hispanic/Latino population is still unknown. This study aimed to examine the longitudinal associations of SDB and insomnia, individually and jointly, with incident MS risk over a 6-year follow-up period in a Hispanic/Latino cohort. Methods: We conducted Cox regression analysis in 4625 participants (mean age 44.5±13.4 years, 60.3% women) who did not have MS at baseline, from the main Hispanic Community Health Study/Study of Latinos study, adjusting for potential covariates, such as age, sex, BMI, and smoking status. MS was defined by the NCEP ATP-III standard, and SDB (apnea-hypopnea index ≥5) and insomnia (Women's Health Initiative Insomnia Rating Scale score ≥9) were assessed during baseline. Results: The prevalence of incident MS with an average 6-year interval was found to be 23.6%. In the fully adjusted model, SDB showed a significant association with incident MS (HR 1.31, 95% CI 1.10-1.56), and the comorbidity of SDB and insomnia (COMISA) was associated with an even higher risk of incident MS (HR 1.40, 95% CI 1.14-1.72), while insomnia alone showed no significant association. Conclusion: SDB and COMISA were associated with incident MS in the Hispanic/Latino population, and COMISA had a stronger association with MS. These findings underscore the importance of addressing sleep disorders as modifiable risk factors in the prevention and management of MS among the Hispanic/Latino population in the USA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.